Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia

    Juan Ferrando, José M Mir-Bonafé
    Image of study
    TLDR A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.
    In 2016, Goren A and colleagues explored the clinical utility and validity of a sulfotransferase activity assay in guiding treatment for androgenetic alopecia (AGA). The researchers conducted an assay procedure on plucked anagen hairs from AGA patients, immersing them in a solution and measuring the optical absorbance at 405nm with a spectrophotometer. They found that a value of less than 0.4 absorbance units indicated low follicular sulfotransferase activity. The assay was able to predict response to 5% topical minoxidil therapy with a sensitivity of 100% and a specificity of 71%. This test could potentially rule out nonresponders to minoxidil, reducing the side effects, emotional stress, and expense associated with using an ineffective drug.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    3 / 3 results